Full View

Safety of nivolumab plus low‐dose ipilimumab in previously treated microsatellite instability‐high/mismatch repair‐deficient metastatic colorectal cancer

MA Morse, MJ Overman, L Hartman, T Khoukaz… - The …, 2019 - academic.oup.com
Background Early detection and management of treatment‐related adverse events (TRAEs)
in patients receiving immune checkpoint inhibitors may improve outcomes. In CheckMate …
被引用次数：107 相关文章
[HTML] nih.gov

[HTML][HTML] Safety of Nivolumab plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer

MA Morse, MJ Overman, L Hartman, T Khoukaz… - The …, 2019 - ncbi.nlm.nih.gov
Background. Early detection and management of treatment‐related adverse events (TRAEs)
in patients receiving immune checkpoint inhibitors may improve outcomes. In CheckMate …
[PDF] wiley.com

[PDF][PDF] Safety of Nivolumab plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer

MA Morse, MJ Overman, L Hartman, T Khoukaz… - The …, 2019 - Wiley Online Library
Background Early detection and management of treatment‐related adverse events (TRAEs)
in patients receiving immune checkpoint inhibitors may improve outcomes. In CheckMate …

Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer.

MA Morse, MJ Overman, L Hartman, T Khoukaz… - The …, 2019 - europepmc.org
Background Early detection and management of treatment-related adverse events (TRAEs)
in patients receiving immune checkpoint inhibitors may improve outcomes. In CheckMate …

Safety of Nivolumab plus Low‐Dose Ipilimumab in Previously Treated Microsatellite Instability‐High/Mismatch Repair‐Deficient Metastatic Colorectal Cancer.

MA Morse, MJ Overman, L Hartman, T Khoukaz… - …, 2019 - search.ebscohost.com
Background. Early detection and management of treatmentrelated adverse events (TRAEs)
in patients receiving immune checkpoint inhibitors may improve outcomes. In CheckMate …

Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer

MA Morse, MJ Overman, L Hartman… - The …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Early detection and management of treatment-related adverse events (TRAEs)
in patients receiving immune checkpoint inhibitors may improve outcomes. In CheckMate …

Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer

MA Morse, MJ Overman, L Hartman… - …, 2019 - mdanderson.elsevierpure.com
Background: Early detection and management of treatment-related adverse events (TRAEs)
in patients receiving immune checkpoint inhibitors may improve outcomes. In CheckMate …